We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular-Based Techniques Diagnose Leprosy

By LabMedica International staff writers
Posted on 23 Apr 2014
Print article
Image: A photomicrograph of Mycobacterium leprae, the small brick-red rods, taken from a leprosy skin lesion (Photo courtesy of Centers of Disease Control and Prevention).
Image: A photomicrograph of Mycobacterium leprae, the small brick-red rods, taken from a leprosy skin lesion (Photo courtesy of Centers of Disease Control and Prevention).
The classic tools to diagnose leprosy are based on bacillary counts and histopathology, but these have been facing hurdles, especially in distinguishing latent infection from active disease and diagnosing paucibacillary clinical forms.

Serological tests and interferon gamma (IFN-γ) releasing assays (IGRA) that employ humoral and cellular immune parameters, respectively, are also being used, but recent results indicate that quantitative polymerase chain reaction (qPCR) is a key technique due to its higher sensitivity and specificity.

Scientists at the Instituto Oswaldo Cruz (Rio de Janeiro, Brazil) have evaluated the various molecular assays now being used to detect Mycobacterium leprae, the causative agent of leprosy. Advances concerning the structure and function of the M. leprae genome led to the development of specific PCR-based gene amplification assays for leprosy diagnosis and monitoring of household contacts.

Some of their findings suggest that commercial kits can be used to extract, purify and amplify M. leprae DNA, ribonucleic acid (RNA), or both. Samples can also be easily stored in 70% ethanol and fast technology for analysis of nucleic acids (FTA) cards (Whatman, Maidstone, UK) for M. leprae DNA detection. Irrespective of whether the detection method used is conventional or real-time PCR, smaller PCR products allow for better amplification efficiency from DNA extracted from either formalin- or ethanol-fixed or fresh tissues. In fact, an important advance has been the real-time PCR technology.

While PCR diagnosis is not needed for lepromatous patients with high bacillary load and high number of lesions, it is extremely helpful for the diagnosis of the situations such as clinical presentations with scarce number of M. leprae bacilli (paucibacillary) and difficult-to-diagnose patients. The detection of M. leprae DNA in different samples of the household contacts of leprosy patients is very promising. Although a positive PCR result is not sufficient to establish a causal relationship with disease outcome, quantitation provided by qPCR is clearly capable of indicating increased risk of developing the disease and could alert clinicians to follow these contacts more closely or even define rules for chemoprophylaxis.

The authors concluded that overall, extensive evaluation of PCR tests in field studies has shown that DNA-based PCR assays can be 100% specific, while the sensitivity ranges from 34% to 80% in patients with paucibacillary forms to greater than 90% in patients with multibacillary forms of the disease. PCR has been ascertained to be especially valuable in diagnosing difficult cases like pure neural leprosy, paucibacillary, and patients with atypical clinical presentation and histopathological features compatible with leprosy. The study was published on April 10, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Instituto Oswaldo Cruz
Whatman 

Related Links:
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.